-
Signature
-
/s/ Bradley K. Serwin, as attorney-in-fact
-
Issuer symbol
-
COMP
-
Transactions as of
-
14 Feb 2025
-
Net transactions value
-
-$25,044,667
-
Form type
-
4
-
Filing time
-
19 Feb 2025, 21:01:04 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
COMP |
Class A Common Stock |
Sale |
$6,131,567 |
-775,490 |
-68% |
$7.91 |
363,646 |
14 Feb 2025 |
Direct |
F1, F2 |
| transaction |
COMP |
Class A Common Stock |
Award |
$0 |
+1,636,354 |
+450% |
$0.000000 |
2,000,000 |
19 Feb 2025 |
Direct |
F3, F4 |
| transaction |
COMP |
Class A Common Stock |
Sale |
$8,978,400 |
-1,000,000 |
-50% |
$8.98 |
1,000,000 |
19 Feb 2025 |
Direct |
F1, F5 |
| transaction |
COMP |
Class A Common Stock |
Sale |
$9,934,700 |
-1,000,000 |
-100% |
$9.93 |
0 |
19 Feb 2025 |
Direct |
F1, F6 |
| holding |
COMP |
Class A Common Stock |
|
|
|
|
|
7,828,116 |
14 Feb 2025 |
See Footnotes |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
COMP |
Class C Common Stock |
Disposed to Issuer |
$0 |
-1,636,354 |
-21% |
$0.000000 |
5,997,433 |
19 Feb 2025 |
Class A Common Stock |
1,636,354 |
|
Direct |
F3, F4 |
| holding |
COMP |
Class C Common Stock |
|
|
|
|
|
4,125,000 |
14 Feb 2025 |
Class A Common Stock |
4,125,000 |
|
See footnote |
F4, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: